These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 11095997

  • 41. Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonates.
    Mutlu M, Yılmaz G, Aslan Y, Bayramoğlu G.
    J Microbiol Immunol Infect; 2011 Dec; 44(6):467-72. PubMed ID: 21606009
    [Abstract] [Full Text] [Related]

  • 42. Optimizing therapy for Stenotrophomonas maltophilia.
    Muder RR.
    Semin Respir Crit Care Med; 2007 Dec; 28(6):672-7. PubMed ID: 18095231
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.
    Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I.
    Cancer; 2007 Jun 15; 109(12):2615-22. PubMed ID: 17487860
    [Abstract] [Full Text] [Related]

  • 45. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
    Tokatly Latzer I, Paret G, Rubinstein M, Keller N, Barkai G, Pessach IM.
    Pediatr Infect Dis J; 2018 Oct 15; 37(10):981-986. PubMed ID: 29634621
    [Abstract] [Full Text] [Related]

  • 46. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.
    Mori M, Tsunemine H, Imada K, Ito K, Kodaka T, Takahashi T.
    Ann Hematol; 2014 Jun 15; 93(6):901-11. PubMed ID: 24535696
    [Abstract] [Full Text] [Related]

  • 47. Association of Stenotrophomonas maltophilia infection with lower airway disease in the horse: a retrospective case series.
    Winther L, Andersen RM, Baptiste KE, Aalbæk B, Guardabassi L.
    Vet J; 2010 Dec 15; 186(3):358-63. PubMed ID: 19758829
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates.
    Tsay RW, Lin LC, Chiou CS, Liao JC, Chen CH, Liu CE, Young TG.
    J Microbiol Immunol Infect; 2005 Jun 15; 38(3):194-9. PubMed ID: 15986070
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Nosocomial Stenotrophomonas maltophilia cross-infection: three cases in newborns.
    Gulcan H, Kuzucu C, Durmaz R.
    Am J Infect Control; 2004 Oct 15; 32(6):365-8. PubMed ID: 15454897
    [Abstract] [Full Text] [Related]

  • 52. Significance and characterisation of pseudomonads from urinary tract specimens.
    Taneja N, Meharwal SK, Sharma SK, Sharma M.
    J Commun Dis; 2004 Mar 15; 36(1):27-34. PubMed ID: 16295683
    [Abstract] [Full Text] [Related]

  • 53. Stenotrophomonas maltophilia pneumonia in a premature infant.
    Ozkan H, Paşaoğlu G, Olgaç N, Günel R, Yüce A, Gülay Z.
    Turk J Pediatr; 1999 Mar 15; 41(2):283-6. PubMed ID: 10770672
    [Abstract] [Full Text] [Related]

  • 54. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
    Venditti M, Monaco M, Micozzi A, Tarasi A, Friedrich A, Martino P.
    Clin Microbiol Infect; 2001 Jan 15; 7(1):37-9. PubMed ID: 11284945
    [No Abstract] [Full Text] [Related]

  • 55. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH, Lin JC, Lin HA, Chang FY, Wang NC, Chiu SK, Lin TY, Yang YS, Kan LP, Yang CH, Chan MC, Yeh KM.
    J Microbiol Immunol Infect; 2016 Jun 15; 49(3):378-86. PubMed ID: 25081988
    [Abstract] [Full Text] [Related]

  • 56. Endophthalmitis caused by Stenotrophomonas maltophilia.
    Chen KJ, Wang NK, Sun MH, Chen TL, Lai CC, Wu WC, Tan HY.
    Ophthalmic Surg Lasers Imaging; 2010 Sep 22; 41(5):e555-61. PubMed ID: 20873692
    [Abstract] [Full Text] [Related]

  • 57. Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.
    Sannathimmappa MB, Nambiar V, Aravindakshan R, Al-Kasaby NM.
    Sultan Qaboos Univ Med J; 2021 Feb 22; 21(1):e66-e71. PubMed ID: 33777425
    [Abstract] [Full Text] [Related]

  • 58. Risk factors for mortality and clinical implications of catheter-related infections in patients with bacteraemia caused by Stenotrophomonas maltophilia.
    Cheong HS, Lee JA, Kang CI, Chung DR, Peck KR, Kim ES, Lee JS, Son JS, Lee NY, Song JH.
    Int J Antimicrob Agents; 2008 Dec 22; 32(6):538-40. PubMed ID: 18715768
    [No Abstract] [Full Text] [Related]

  • 59. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.
    Safdar A, Rolston KV.
    Clin Infect Dis; 2007 Dec 15; 45(12):1602-9. PubMed ID: 18190323
    [Abstract] [Full Text] [Related]

  • 60. Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: A study of 143 patients.
    Gopalakrishnan R, Hawley HB, Czachor JS, Markert RJ, Bernstein JM.
    Heart Lung; 1999 Dec 15; 28(2):134-41. PubMed ID: 10076113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.